JPWO2023035083A5 - - Google Patents

Info

Publication number
JPWO2023035083A5
JPWO2023035083A5 JP2024516396A JP2024516396A JPWO2023035083A5 JP WO2023035083 A5 JPWO2023035083 A5 JP WO2023035083A5 JP 2024516396 A JP2024516396 A JP 2024516396A JP 2024516396 A JP2024516396 A JP 2024516396A JP WO2023035083 A5 JPWO2023035083 A5 JP WO2023035083A5
Authority
JP
Japan
Prior art keywords
polypeptide
ferritin
fusion polypeptide
subunit
self
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024516396A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024533487A (ja
JP2024533487A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2022/051360 external-priority patent/WO2023035083A1/en
Publication of JP2024533487A publication Critical patent/JP2024533487A/ja
Publication of JPWO2023035083A5 publication Critical patent/JPWO2023035083A5/ja
Publication of JP2024533487A5 publication Critical patent/JP2024533487A5/ja
Pending legal-status Critical Current

Links

JP2024516396A 2021-09-13 2022-09-13 最適化されたMultabody構築物、組成物、及び方法 Pending JP2024533487A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163243402P 2021-09-13 2021-09-13
US63/243,402 2021-09-13
PCT/CA2022/051360 WO2023035083A1 (en) 2021-09-13 2022-09-13 Optimized multabody constructs, compositions, and methods

Publications (3)

Publication Number Publication Date
JP2024533487A JP2024533487A (ja) 2024-09-12
JPWO2023035083A5 true JPWO2023035083A5 (https=) 2025-09-24
JP2024533487A5 JP2024533487A5 (https=) 2025-09-24

Family

ID=85506121

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024516396A Pending JP2024533487A (ja) 2021-09-13 2022-09-13 最適化されたMultabody構築物、組成物、及び方法

Country Status (9)

Country Link
US (1) US20240400704A1 (https=)
EP (1) EP4402179A4 (https=)
JP (1) JP2024533487A (https=)
KR (1) KR20240102943A (https=)
CN (1) CN118488971A (https=)
AU (1) AU2022343032A1 (https=)
CA (1) CA3231173A1 (https=)
MX (1) MX2024003140A (https=)
WO (1) WO2023035083A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022543070A (ja) * 2019-08-01 2022-10-07 ザ ホスピタル フォー シック チルドレン 多価及び多重特異性ナノ粒子プラットフォーム及び方法
AU2022212978A1 (en) * 2021-01-28 2023-08-31 The Hospital For Sick Children Multabody constructs, compositions, and methods

Similar Documents

Publication Publication Date Title
JP7641967B2 (ja) ヒト化cldn18.2抗体
JP2021522162A5 (https=)
JP2020114210A5 (https=)
JP2019502694A5 (https=)
CN107206077A (zh) 靶向g‑蛋白偶联受体的抗体和使用方法
JP2021503455A5 (https=)
JP2020517287A5 (https=)
CN116063508A (zh) 靶向Fc受体样5的抗体及使用方法
JP2017504578A5 (https=)
JP2011526249A5 (https=)
JP2011501951A5 (https=)
CA3173414A1 (en) Pd-1 agonist multimeric binding molecules
JP2022009816A5 (https=)
WO2018119118A4 (en) Lymphotoxin-beta receptor-binding agents, targeting antibodies, and uses thereof
JPWO2019204564A5 (https=)
JP2025124718A5 (https=)
JPWO2021030483A5 (https=)
JPWO2019121906A5 (ja) Pd-li抗原結合部位を有するfc結合断片
JPWO2020247871A5 (https=)
JPWO2023034922A5 (https=)
JPWO2023035083A5 (https=)
FI3681911T3 (fi) Ihmisen trombiinireseptori PAR4:ään sitoutuvia proteiineja
WO2024017281A1 (zh) 多特异性抗体及其用途
WO2024061224A1 (zh) 抗her2抗体及其用途
RU2024109942A (ru) Оптимизированные конструкции multabody, композиции и способы